Form 4: Precigen Director Kindler Boosts Equity Stake

Precigen Director Jeffrey B. Kindler acquired common stock, restricted stock units, and stock options as part of his compensation.

Summary

• Director Jeffrey B. Kindler acquired 19,658 shares of Precigen Common Stock at a price of $3.51 per share.
• These shares were issued in lieu of an annual retainer totaling $69,000.
• Following this transaction, Kindler's direct beneficial ownership of common stock is 130,261 shares.
• He also acquired 35,612 Restricted Stock Units (RSUs), with each RSU representing a contingent right to receive one share of Precigen common stock.
• The acquired RSUs are scheduled to vest in full on March 10, 2027.
• Additionally, Kindler received options to purchase 41,073 shares of Common Stock at an exercise price of $3.51.
• These stock options became exercisable on March 10, 2026, and will expire on March 10, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates a director's continued commitment to the company through increased equity ownership, aligning their interests with shareholders.

Positives

• Director Kindler increased his direct ownership in Precigen by acquiring 19,658 shares of common stock, aligning his interests with shareholders.
• The acquisition of Restricted Stock Units and stock options further ties the director's compensation to the company's long-term performance and shareholder value creation.

Negatives

• NA

Risks

• NA

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule for Restricted Stock Units and the expiration date for stock options.

Management Comments

• NA

Industry Context

StockSavvy.ai notes that director equity compensation, including common stock, RSUs, and stock options, is a standard practice across industries, particularly in biotechnology and pharmaceutical sectors like Precigen's, to align executive and director incentives with long-term company performance and shareholder interests. This type of compensation structure is common for companies seeking to retain key talent and encourage commitment to strategic goals.

Comparison to Industry Standards

• The use of equity as a significant component of director compensation, including common stock, RSUs, and stock options, is a widely accepted practice in the U.S. market, comparable to compensation structures seen at biotech peers such as Moderna (MRNA) or BioNTech (BNTX), where a substantial portion of director pay is often equity-based to foster long-term alignment.
• The specific vesting schedule for RSUs (one year) and the ten-year term for stock options are within typical industry ranges for director equity awards, reflecting standard corporate governance practices aimed at balancing immediate recognition with sustained commitment.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• The acquisition of common stock, restricted stock units, and stock options by Director Jeffrey B. Kindler constitutes a related party transaction as part of his compensation package.

Stakeholder Impact

• Shareholders: Increased director ownership may signal confidence in the company's future, potentially aligning director interests more closely with shareholder value creation.

Next Steps

• RSUs are scheduled to vest in full on March 10, 2027.
• Stock options are exercisable from March 10, 2026, until their expiration on March 10, 2036.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation for a director, which is a standard practice and does not present new information that would significantly alter the investment thesis for Precigen. While increased insider ownership is generally positive, this specific transaction is expected and does not warrant a change in investment recommendation based solely on this filing.

Keywords

Precigen, PGEN, Jeffrey B. Kindler, Director, Insider Transaction, Form 4, Equity Compensation, Common Stock, Restricted Stock Units, Stock Options